Does Vyvanse (lisdexamfetamine) show up on a drug test?

Official answer

by Modadiary.com

If you take Vyvanse—whether it’s for ADHD, binge eating disorder, or other health reasons—you might wonder: can this medication affect your drug test results? Let’s break it down in simple terms so you understand how Vyvanse interacts with common drug screenings.

Vyvanse (lisdexamfetamine) is a central nervous system stimulant. After ingestion, it’s converted into dextroamphetamine, an active ingredient that may trigger a positive result on drug tests for amphetamines. Whether you’re prescribed this medication or not, knowing when and how it can be detected can save you from unnecessary stress or misunderstandings.

What is Vyvanse Detection Time in Drug Tests?

Vyvanse is designed to be a long-acting medication, but how long it remains detectable varies depending on the type of test. Here are some approximate detection windows:

  • Urine Test: Up to 3–5 days
  • Saliva Test: Up to 48 hours
  • Blood Test: Approximately 7–34 hours
  • Hair Follicle Test: Up to 90 days

The detection time differs based on factors like dosage, frequency of use, metabolism, age, kidney function, and hydration levels.

Why Does Vyvanse Show Up on Drug Tests?

Vyvanse breaks down into dextroamphetamine in your body, which is flagged as an amphetamine—a substance commonly screened for in drug tests. Most standard drug tests don’t differentiate whether the amphetamine is from prescription use or illegal substances. If you’ve taken Vyvanse as prescribed, this could lead to confusion during routine screenings.

Think of it this way: drug tests are blunt instruments. While they can detect the presence of amphetamines, they won’t distinguish between medications like Vyvanse and illicit drug use unless further analysis is conducted.

What If I Am Prescribed Vyvanse and Have a Drug Screening?

You’re not alone in worrying about this! Having a legitimate prescription for Vyvanse means there’s little to be concerned about—provided you plan and communicate effectively. Here’s what you can do:

  1. Tell Your Employer or Tester
    If the screening is job-related or medical, inform the testing agency or employer that you’ve been prescribed Vyvanse. Transparency goes a long way; bring a copy of your prescription as proof.
  2. Provide Documentation
    Your doctor can provide a written note or documentation confirming the prescription and explaining its use. This can help prevent misunderstandings when amphetamines are detected.
  3. Be Prepared for Further Tests
    If your initial test flags amphetamines, a lab may use more specific testing methods (like gas chromatography-mass spectrometry) to identify the exact source of the detected substance.

Vyvanse is a controlled substance but not an illegal drug. This distinction should help you navigate your next screening with confidence. Keep in mind that maintaining open communication with the involved parties is key.

Factors That Influence Vyvanse Detection

Several factors can impact how long Vyvanse stays detectable in your system:

  • Frequency and Duration of Use: Daily use leads to higher accumulation.
  • Metabolic Rate: Faster metabolism clears the drug quicker.
  • Liver and Kidney Health: Impaired organs may extend detection time.
  • Dose Taken: Higher doses stay in the system longer.

Understanding these variables can help you better estimate when Vyvanse will leave your body. Still, since these factors vary widely from person to person, consulting your physician is always a good idea.

Conclusion

Does Vyvanse show up on a drug test? Yes, it does—often as an amphetamine. But if you’re taking Vyvanse under a doctor’s supervision, it’s nothing to worry about. Be upfront about your prescription and prepared to provide documentation if needed.

Whether you’re prepping for a work-related test, a DOT screening, or any other panel, knowledge is your friend. Understanding exactly how Vyvanse interacts with drug tests doesn’t just help you—it gives you peace of mind.

References

  1. accessdata.fda.gov/drugsatfda_docs/label/2017/208510lbl.pdf

Featured Experts

Stay Informed